| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0000084 | Mitotic s phase | Affects phenotype | PMID:34677630 |
| GO:0000086 | G2/m transition of mitotic cell cycle | Affects phenotype | PMID:34677630 |
| GO:0001819 | Positive regulation of cytokine production | Increases phenotype | PMID:28935500 |
| GO:0002377 | Immunoglobulin production | Affects phenotype | PMID:38763499 |
| GO:0002639 | Positive regulation of immunoglobulin production | Increases phenotype | PMID:28935500; PMID:33170220 |
| GO:0002693 | Positive regulation of cellular extravasation | Increases phenotype | PMID:31034930 |
| GO:0002866 | Positive regulation of acute inflammatory response to antigenic stimulus | Increases phenotype | PMID:33170220 |
| GO:0004035 | Alkaline phosphatase activity | Increases phenotype | PMID:34400200 |
| GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity | Increases phenotype | PMID:34400200; PMID:35925383; PMID:35925383 |
| GO:0004602 | Glutathione peroxidase activity | Affects phenotype | PMID:18636399; PMID:34400200; PMID:34673182; PMID:35090964 |
| GO:0004784 | Superoxide dismutase activity | Affects phenotype | PMID:34673182; PMID:35090964; PMID:37705238 |
| GO:0006110 | Regulation of glycolytic process | Affects phenotype | PMID:38040082 |
| GO:0006111 | Regulation of gluconeogenesis | Affects phenotype | PMID:38040082 |
| GO:0006260 | Dna replication | Increases phenotype | PMID:32416088 |
| GO:0006304 | Dna modification | Increases phenotype | PMID:35817260 |
| GO:0006308 | Dna catabolic process | Increases phenotype | PMID:34677630 |
| GO:0006412 | Translation | Decreases phenotype | PMID:37315771 |
| GO:0006693 | Prostaglandin metabolic process | Affects phenotype | PMID:32416088 |
| GO:0006749 | Glutathione metabolic process | Increases phenotype | PMID:30244016 |
| GO:0006750 | Glutathione biosynthetic process | Decreases phenotype | PMID:18636399; PMID:26115597 |
| GO:0006810 | Transport | Affects phenotype | PMID:37315771 |
| GO:0006874 | Cellular calcium ion homeostasis | Affects phenotype | PMID:33309878 |
| GO:0006879 | Cellular iron ion homeostasis | Affects phenotype | PMID:39983889 |
| GO:0006914 | Autophagy | Increases phenotype | PMID:34677630 |
| GO:0006915 | Apoptotic process | Increases phenotype | PMID:20347963; PMID:20347963; PMID:33309878; PMID:27350164; PMID:27757495; PMID:33309878; PMID:34506767; PMID:34673182; PMID:34677630; PMID:35090964; PMID:35925383; PMID:37705238; PMID:38763499 |
| GO:0006954 | Inflammatory response | Increases phenotype | PMID:32416088; PMID:34400200; PMID:35090964 |
| GO:0006974 | Cellular response to dna damage stimulus | Increases phenotype | PMID:26115597; PMID:34677630 |
| GO:0006979 | Response to oxidative stress | Increases phenotype | PMID:20347963; PMID:24355168; PMID:30169763 |
| GO:0007005 | Mitochondrion organization | Decreases phenotype | PMID:34673182; PMID:35817260 |
| GO:0008219 | Cell death | Increases phenotype | PMID:18636399; PMID:27757495 |
| GO:0008283 | Cell population proliferation | Affects phenotype | PMID:24937323; PMID:24937323; PMID:32416088; PMID:26783879; PMID:27350164; PMID:32416088 |
| GO:0008284 | Positive regulation of cell population proliferation | Affects phenotype | PMID:28935499; PMID:35588983 |
| GO:0008285 | Negative regulation of cell population proliferation | Increases phenotype | PMID:30244016; PMID:30244016; PMID:35314294; PMID:37419272; PMID:32738333; PMID:35588983; PMID:37419272 |
| GO:0008343 | Adult feeding behavior | Decreases phenotype | PMID:34506767 |
| GO:0010759 | Positive regulation of macrophage chemotaxis | Increases phenotype | PMID:33170220 |
| GO:0010942 | Positive regulation of cell death | Increases phenotype | PMID:24355168; PMID:28013001; PMID:28865950; PMID:28935499; PMID:30169763 |
| GO:0015707 | Nitrite transport | Increases phenotype | PMID:21748807 |
| GO:0015721 | Bile acid and bile salt transport | Affects phenotype | PMID:35224661 |
| GO:0016042 | Lipid catabolic process | Increases phenotype | PMID:26115597; PMID:34673182 |
| GO:0016049 | Cell growth | Decreases phenotype | PMID:18636399; PMID:30668976; PMID:30716354 |
| GO:0019369 | Arachidonic acid metabolic process | Affects phenotype | PMID:38040082 |
| GO:0019646 | Aerobic electron transport chain | Decreases phenotype | PMID:28013001 |
| GO:0030199 | Collagen fibril organization | Increases phenotype | PMID:35925383 |
| GO:0030263 | Apoptotic chromosome condensation | Increases phenotype | PMID:38763499 |
| GO:0030284 | Nuclear estrogen receptor activity | Increases phenotype | PMID:27481073 |
| GO:0030335 | Positive regulation of cell migration | Increases phenotype | PMID:38432439 |
| GO:0033212 | Iron import into cell | Increases phenotype | PMID:37419272 |
| GO:0034440 | Lipid oxidation | Increases phenotype | PMID:35817260; PMID:39983889 |
| GO:0035684 | Helper t cell extravasation | Increases phenotype | PMID:33170220 |
| GO:0035754 | B cell chemotaxis | Increases phenotype | PMID:33170220 |
| GO:0036146 | Cellular response to mycotoxin | Increases phenotype | PMID:23719927; PMID:24355168 |
| GO:0036335 | Intestinal stem cell homeostasis | Affects phenotype | PMID:34506767 |
| GO:0040015 | Negative regulation of multicellular organism growth | Increases phenotype | PMID:35817260 |
| GO:0043032 | Positive regulation of macrophage activation | Increases phenotype | PMID:39725263 |
| GO:0043065 | Positive regulation of apoptotic process | Affects phenotype | PMID:30169763; PMID:32738333; PMID:35817260; PMID:39153657 |
| GO:0043066 | Negative regulation of apoptotic process | Increases phenotype | PMID:32738333 |
| GO:0044237 | Cellular metabolic process | Decreases phenotype | PMID:21748807; PMID:30251759; PMID:32065293; PMID:33309878; PMID:34673182; PMID:34677630; PMID:35090964; PMID:35925383; PMID:37705238; PMID:38549690 |
| GO:0044256 | Protein digestion | Affects phenotype | PMID:38040082 |
| GO:0044319 | Wound healing, spreading of cells | Decreases phenotype | PMID:30854615 |
| GO:0045023 | G0 to g1 transition | Affects phenotype | PMID:34677630 |
| GO:0045454 | Cell redox homeostasis | Decreases phenotype | PMID:35817260; PMID:37419272; PMID:38040082 |
| GO:0045627 | Positive regulation of t-helper 1 cell differentiation | Increases phenotype | PMID:28935500 |
| GO:0045738 | Negative regulation of dna repair | Affects phenotype | PMID:24355168 |
| GO:0045930 | Negative regulation of mitotic cell cycle | Increases phenotype | PMID:30169763; PMID:30286430 |
| GO:0046209 | Nitric oxide metabolic process | Affects phenotype | PMID:34673182 |
| GO:0046330 | Positive regulation of jnk cascade | Increases phenotype | PMID:30169763 |
| GO:0046466 | Membrane lipid catabolic process | Affects phenotype | PMID:24355168 |
| GO:0048863 | Stem cell differentiation | Decreases phenotype | PMID:34506767 |
| GO:0048874 | Host-mediated regulation of intestinal microbiota composition | Increases phenotype | PMID:30981666; PMID:31034930 |
| GO:0050729 | Positive regulation of inflammatory response | Increases phenotype | PMID:35314294 |
| GO:0050766 | Positive regulation of phagocytosis | Increases phenotype | PMID:38432439 |
| GO:0050995 | Negative regulation of lipid catabolic process | Increases phenotype | PMID:38040082 |
| GO:0050996 | Positive regulation of lipid catabolic process | Increases phenotype | PMID:37419272 |
| GO:0051881 | Regulation of mitochondrial membrane potential | Affects phenotype | PMID:33309878; PMID:34673182; PMID:37705238 |
| GO:0051882 | Mitochondrial depolarization | Increases phenotype | PMID:34677630 |
| GO:0051899 | Membrane depolarization | Increases phenotype | PMID:37705238 |
| GO:0051938 | L-glutamate import | Affects phenotype | PMID:21748807 |
| GO:0060729 | Intestinal epithelial structure maintenance | Decreases phenotype | PMID:35817260 |
| GO:0061024 | Membrane organization | Affects phenotype | PMID:33890134 |
| GO:0070265 | Necrotic cell death | Increases phenotype | PMID:38763499 |
| GO:0070269 | Pyroptosis | Increases phenotype | PMID:35925383 |
| GO:0070633 | Transepithelial transport | Decreases phenotype | PMID:35817260 |
| GO:0070994 | Detection of oxidative stress | Increases phenotype | PMID:34677630 |
| GO:0071736 | Igg immunoglobulin complex, circulating | Affects phenotype | PMID:38763499 |
| GO:0071746 | Iga immunoglobulin complex, circulating | Affects phenotype | PMID:38763499 |
| GO:0072593 | Reactive oxygen species metabolic process | Affects phenotype | PMID:33309878; PMID:35090964; PMID:37705238 |
| GO:0072683 | T cell extravasation | Increases phenotype | PMID:36602574 |
| GO:0090136 | Epithelial cell-cell adhesion | Decreases phenotype | PMID:35817260 |
| GO:0090200 | Positive regulation of release of cytochrome c from mitochondria | Increases phenotype | PMID:35817260 |
| GO:0090557 | Establishment of endothelial intestinal barrier | Decreases phenotype | PMID:34506767 |
| GO:0097212 | Lysosomal membrane organization | Decreases phenotype | PMID:29174985 |
| GO:0120193 | Tight junction organization | Decreases phenotype | PMID:35817260 |
| GO:0140042 | Lipid droplet formation | Increases phenotype | PMID:35925383 |
| GO:0140354 | Lipid import into cell | Increases phenotype | PMID:38040082 |
| GO:0140911 | Pore-forming activity | Increases phenotype | PMID:35925383 |
| GO:0160020 | Positive regulation of ferroptosis | Increases phenotype | PMID:37419272 |
| GO:1900017 | Positive regulation of cytokine production involved in inflammatory response | Increases phenotype | PMID:33170220 |
| GO:1900181 | Negative regulation of protein localization to nucleus | Increases phenotype | PMID:35817260 |
| GO:1900182 | Positive regulation of protein localization to nucleus | Increases phenotype | PMID:35817260 |
| GO:1903047 | Mitotic cell cycle process | Affects phenotype | PMID:34677630 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Increases phenotype | PMID:18636399; PMID:26783879 |
| GO:1903428 | Positive regulation of reactive oxygen species biosynthetic process | Affects phenotype | PMID:28013001; PMID:30169763; PMID:35817260; PMID:37419272; PMID:37419272; PMID:39147090; PMID:39153657 |
| GO:1903999 | Negative regulation of eating behavior | Increases phenotype | PMID:25787141; PMID:35817260 |
| GO:1905448 | Positive regulation of mitochondrial atp synthesis coupled electron transport | Decreases phenotype | PMID:28013001 |
| GO:1905517 | Macrophage migration | Increases phenotype | PMID:35925383 |
| GO:2000321 | Positive regulation of t-helper 17 cell differentiation | Increases phenotype | PMID:28935500 |
| GO:2000391 | Positive regulation of neutrophil extravasation | Increases phenotype | PMID:33170220 |
| GO:2000421 | Positive regulation of eosinophil extravasation | Increases phenotype | PMID:33170220 |
| GO:2000510 | Positive regulation of dendritic cell chemotaxis | Increases phenotype | PMID:33170220 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.